pharma-company /Medicinal products /Active ingredients

Rx · PZN 11676019, 11676031

BETMIGA 50 mg prolonged-release tablets

German trade nameBETMIGA 50 mg Retardtabletten

Active ingredientMirabegronPharmaceutical formProlonged-release tablets

Only sporadically available

1.7

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Ambient 15–25 °C

Average purchase price (B2B)

~ €53

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for BETMIGA 50 mg prolonged-release tablets.

Review purchasing terms

BETMIGA 50 mg prolonged-release tablets contains the active ingredient Mirabegron and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.3 to 1.7 out of 10. The best-available pack was only sporadically available.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
116760191.81.7~ €29
116760310.20.3~ €77

BETMIGA 50 mg prolonged-release tablets was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.